Johnson & Johnson  El American

Johnson & Johnson Plans to Test Coronavirus Vaccine on Infants

The drug company plans to test the drug first in children between the ages of 12 and 18 and THEN move up the age range

[Leer en español]

Drugmaker Johnson & Johnson plans to test its vaccine in newborns, according to a report from the The New York Times.

The trials, which would also include pregnant women and people with compromised immune systems, would have the approval of Ofer Levy, Director of the Precision Vaccines Program at Harvard’s Boston Children’s Hospital and a member of the Food and Drug Administration’s (FDA) advisory committee.

Johnson & Johnson’s plan would be to first test the drug in children over 12 and under 18, and immediately begin a study involving newborns and adolescents.

The company will then test its vaccine in pregnant women and, finally, in immunocompromised individuals. Like the other companies, Johnson & Johnson will analyze safety and immune responses.

The FDA approved on Saturday emergency clearance of Johnson & Johnson’s COVID-19 vaccine, which requires a single injection, and will be the third to be available in the country.

So far, no trials involving children under 12 have been conducted. Only PfizerBioNTech has the authorization to immunize people 16 years and older.

Is Biden to Blame For The Dramatic Rise of Inflation?*
This poll gives you free access to our premium politics newsletter. Unsubscribe at any time.
This field is for validation purposes and should be left unchanged.

Currently PfizerBioNTech and Moderna are conducting trials in children aged 12 to 16 years. The majority of the global vaccine market is for pediatric vaccines.

Previous Article

Candace Owens, the African-American Conservative with Presidential Ambitions

Next Article

Gov. Andrew Cuomo Under Investigation for Alleged Sexual Harassment

Related Posts